论文信息 - Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. - 字舞流文

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.

H. Wakelee | L. Sequist | D. Grimm | J. Soria | D. Camidge | S. Bentink | S. Gadgeel | D. Enderle | M. Raponi | J. Goldman | J. Skog | A. Spiel | M. Noerholm | C. Karlovich | J. Emenegger | A. Krug | E. Castellanos-Rizaldos | K. Brinkmann | T. Priewasser

[1] J. Berenguer,et al. Combining plasma-based biosources to predict treatment response in NSCLC patients. , 2018 .

[2] H. Wakelee,et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.